悲痛的父母警告称，如果不更广泛地推广疫苗，MenB 就会爆发

An in-depth investigation reveals how Merck's pricing and patents on the lifesaving cancer drug Keytruda have made it one of the world's top-selling medicines, while leaving many patients unable to afford it.

New research reveals private companies made £1.6 billion in profits from NHS contracts over 2 years, with millions going to firms in tax havens. Critics demand a cap on profits.